The European Commission’s proposed directive to clamp down on counterfeit medicines “cannot ignore” the reality that a “huge percentage” of counterfeits are channelled through the internet, says the new rapporteur for the proposal in Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI).
Maria Matias was speaking at a meeting in Parliament on Making Patient Safety a Priority, organised by Aegate, the UK-based company that supplies a pharmacy-level authentication system to sift out counterfeit drugs from the legitimate supply chain.
While the proposed directive released in December 2008 addressed key points of vulnerability in the legal supply chain, the Commission left internet trade to the discretion of the member states, placing it in the wider context of whether national governments allowed sales of prescription medicines online. The issue had already been raised by Adamos Adamou, the previous ENVI rapporteur before the European parliamentary elections last June.
For full article, please see PharmaTimes.
Tags: Authentication · counterfeit drugs · EU · European Federation of Pharmaceutical Industries and Associations · internet pharmacies · pharmaceuticals · supply chainNo Comments
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.